Bowel Cancer: Preventable, Detectable, But Still Under-Screened
Bowel cancer is one of Australia’s most preventable cancers, yet uptake of screening remains worryingly low. In the Central and Eastern Sydney PHN region, only 37.2% of eligible adults complete the bowel screening test compared to NSW rate (39.5%) and national rate (40.9%)—with participation rates lowest among men and those from multicultural communities and disadvantaged communities.
The National Bowel Cancer Screening Program offers free, mailed faecal immunochemical test (FIT) kits to Australians aged 50–74, enabling early detection and prevention. It’s a proven, accessible way to detect cancer early — where 90% of cases can be treated successfully.
Your role is critical: Brief, opportunistic advice, reminder systems, issuing screening kits directly to patients eligible for the program and proactive follow-up of non-responders can lift participation and save lives.
To increase bowel cancer screening rates, healthcare providers can bulk order kits to issue to eligible patients during an appointment.
The Department of Health, Disability and Ageing website outlines the 5 steps, your practice can follow to help increase the bowel screening rates of eligible people in your community:
Register for access to the National Cancer Screening Register Healthcare Provider (HCP) Portal. You can also integrate your clinical software for easier access.
Get training to help you adopt and promote screening in your practice.
Order the free test kits through the portal.
Hand out kits to eligible patients and record this in the portal.
Access resources with culturally tailored options, including an expanded range for Indigenous people to promote participation in the program.
Let’s lead change this Bowel Cancer Awareness Month (June 2025) – normalise screening and help more people take this life-saving step.
Immunisation Weekly Update: Join the Immunisation Working Group Register for free QI activities: Vaccination Recall Programs DVA eligibility for RSV vaccine Maternal Abrysvo ® vaccination program success New National Immunisation Strategy COVID-19 updates Education Join the Immunisation Working Group Vaccination providers are invited to join our Immunisation Working Group to…
Immunisation Weekly Update: Cessation of MBS COVID-19 vaccine support items from 1 July 2025 2025 updates to anaphylaxis training RSV vaccine safety data and resources New NCIRS meningococcal vaccines FAQs resource Influenza vaccination coverage data update Changes to pharmacist vaccination programs Education Cessation of MBS COVID-19 vaccine support items from…
Immunisation Weekly Update: Stay up to date with measles Protecting your patients from the flu First clade 1b mpox case in Australia Remind your patients about RSV and maternal vaccinations in pregnancy New First Nations and childhood vaccination resources Stay up to date with measles Lunch and learn recording and…
Immunisation Weekly Update: Federal ministers and national media react to falling vaccination rates Be mindful of measles before and after Hajj COVID-19 vaccine update and new resource Flu Vaccine Updates ‘Possible but rare’ RSV vaccine risk First Nations maternal vaccinations poster Federal ministers and national media react to falling vaccination…
Immunisation Weekly Update: CESPHN seeking Immunisation Working Group clinical representatives Lunch and Learn: Measles awareness and prevention in 2025 Concerns rise as vaccination rates continue to fall The latest influenza vaccination coverage data Access to existing Q Fever statements in the Q Fever Register to end 30 June 2025 Have…
Immunisation Weekly Update: Lunch and Learn: Measles awareness and prevention in 2025 Australia on track for record number of flu cases Free SMS recall – 2025 Quality Improvement programs Large-scale revamp of Handbook immunocompromised chapter In case you missed it… Beyfortus™ (nirsevimab) eligibility expansion Access to the Australian Immunisation Register…